PATENT CLAIM ANALYSIS

Application Number: 15764859
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "136100"]

Abstract:
The present invention concerns binding molecules that comprise an IgM, IgA, IgG/IgM or IgG/IgA antibody with a J-chain modified to include an AD-ME-modulating moiety, and their uses.

Claim (Index 82):
Use of the binding molecule according to any one of  claims 13 - 28  and  38 - 66  in the preparation of a medicament for treating Alzheimer's disease.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 90.0
- Lexical Diversity: 1.10714
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15452616', '15301366', '13883282', '13473017', '15566485']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7886152133677661
- 35 USC 102 Novelty (BERT): 0.5544955999898686
- Combined Prediction Score: 0.7652032520299763
- Mean Citation Score: 404.834832
- Max Citation Score: 471.7423
- Similarity Product: 289.44207486839287

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test